Author:
Koch Cameron J.,Evans Sydney M.
Publisher
Society of Nuclear Medicine
Subject
Radiology Nuclear Medicine and imaging
Reference7 articles.
1. Comparison of the Hypoxia PET Tracer 18F-EF5 to Immunohistochemical Marker EF5 in 3 Different Human Tumor Xenograft Models
2. Importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules
3. Koch CJ, Lord EM, inventors; Trustees of University of Pennsylvania, University of Rochester, assignee. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. U.S. patent 5540908. July 30, 1996.
4. Koch CJ Evans SM . Optimizing hypoxia detection and treatment strategies. Semin Nucl Med. In press.
5. Koch CJ . The reductive activation of nitroimidazoles; modification by oxygen and other redox-active molecules in cellular systems. In: Adams GE, Breccia A, Fielden EM, Wardman P, eds. Selective Activation of Drugs by Redox Processes. New York, NY: Plenum Press; 1990:237–247.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献